Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
Join us if you want
- To understand how to widen the use of a sirolimus DCB in new and challenging treatment indications
- To know why sirolimus coated balloon is the ideal choice in native vessel disease treatment through a case presentation
- To know what the future has in store for sirolimus coated balloon Upcoming studies and rationale for the Food and Drug Administration
Anchorperson: Patrick W. Serruys
Moderator: Azeem Latib
Discussants: Praveen Chandra, Antonio Colombo, Bernardo Cortese, Sameer Dani, Aloke Finn
Chatmaster: Damiano Regazzoli
Patrick W. Serruys
Aloke Finn
Antonio Colombo
Bernardo Cortese
Aloke Finn
Sameer Dani
Aloke Finn
Patrick W. Serruys